Legislators, Medical Experts, Advocates Launch Statewide Prostate Cancer Education and Awareness Program

Legislators, Medical Experts, Advocates Launch Statewide Prostate Cancer Education and Awareness Program MA, March 12, 2015—AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health. The program, the first of its type statewide, also has the support of legislative leaders and advocacy groups, including…

AdMeTech Foundation announces launch of statewide prostate cancer awareness program

AdMeTech Foundation announces launch of statewide prostate cancer awareness program March 12th  AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health. The program, the first of its type statewide, also has the support of legislative leaders and advocacy groups, including the…

AWARENESS EFFORT LAUNCHED TO HELP DETECT PROSTATE CANCER EARLY

AWARENESS EFFORT LAUNCHED TO HELP DETECT PROSTATE CANCER EARLY   By Colleen Quinn STATE HOUSE NEWS SERVICE STATE HOUSE, BOSTON, MARCH 12, 2015….Public awareness about the prevalence of prostate cancer will boost early detection and decrease medical costs associated with the disease, according to cancer survivors and a doctor involved with research. Thursday is annual…

Western Massachusetts lawmakers team up with Boston non-profit to launch statewide prostate cancer awareness program

Massachusetts lawmakers team up with Boston non-profit to launch statewide prostate cancer awareness program   By Shira Schoenberg March 12th  BOSTON – In 2002, State Rep. Stephen Kulik, D-Worthington, was diagnosed with prostate cancer. The cancer was caught early during a routine annual physical, and Kulik underwent surgery and treatment. He has had a clean…

A new genomic test (Decipher) from GenomeDx identifies men who after radical surgery for prostate cancer have a higher risk of the disease progression and may benefit from adjuvant radiation treatment

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier February 10 GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined…